MONTVALE, N.J., May 7 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) announced today that it will report its first quarter 2008 financial results on Wednesday, May 14, 2008, before the U.S. financial markets open. Management will provide a Company update and discuss the first quarter results during a conference call the same day, at 9:00 a.m. EST.
Investors and other interested parties may access the call as follows: Date: Wednesday, May 14, 2008
Time: 9:00 a.m. EDT
Telephone (U.S.): 866.356.4441
Telephone (international): 617.597.5396
Participant Passcode: 80809977
Webcast: http://www.memorypharma.com/ under the
"Investors" section An audio replay of the conference call will be available from 11:00 a.m. EDT on Wednesday, May 14, 2008, until Wednesday, May 21, 2008. To access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and enter pass code number 14991737. An audio replay of the conference call will also be available under the "Investors" section of the Company's website during the same period.
About Memory Pharmaceuticals Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and schizophrenia. For additional information, please visit our website at http://www.memorypharma.com/. DATASOURCE: Memory Pharmaceuticals Corp.
CONTACT: Jzaneen Lalani, General Counsel, +1-201-802-7249; or Laura Perry, LMP Investor Relations Inc., +1-646-719-1055 Web site: http://www.memorypharma.com/
|